IL6 and asthma: An analysis of U-BIOPRED data reported that adult patients characterized by IL-6 trans-signaling-related epithelial gene signature had upregulated innate immune pathways, type 2 inflammation-independent eosinophilia, increased submucosal inflammation and airway remodeling, and higher asthma exacerbation rate (25).